CreOrgans is a platform that develops and markets bioprinters for the construction of three-dimensional cellularized structures, obtained in physiological conditions suitable for their maintenance and study.
With CreOrgans we want to speed up the process of drug approval and drastically reduce costs by providing researchers the opportunity to carry out more predictive tests, in order to identify toxic or inactive molecules before they are subjected to clinical trials.
